10/29
09:57 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Neutral
Report
Tourmaline Bio (NASDAQ:TRML) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
10/8
05:51 pm
trml
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate Merger – TRML, PNFP, MRCC, and UNP
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate Merger – TRML, PNFP, MRCC, and UNP
10/6
05:24 pm
trml
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
Low
Report
Tourmaline Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
9/16
11:50 am
trml
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AL, TRML, SOL on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AL, TRML, SOL on Behalf of Shareholders
9/15
05:30 pm
trml
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Tourmaline Bio, Inc. (NASDAQ: TRML)
Low
Report
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Tourmaline Bio, Inc. (NASDAQ: TRML)
9/15
08:07 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $35.00.
Medium
Report
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $35.00.
9/14
06:43 pm
trml
Tourmaline Bio (TRML): Assessing Valuation as Market Interest Grows [Yahoo! Finance]
Low
Report
Tourmaline Bio (TRML): Assessing Valuation as Market Interest Grows [Yahoo! Finance]
9/11
02:25 pm
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Piper Sandler. They now have a $48.00 price target on the stock, down previously from $65.00.
Neutral
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Piper Sandler. They now have a $48.00 price target on the stock, down previously from $65.00.
9/11
10:43 am
trml
TOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
Low
Report
TOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
9/11
12:09 am
trml
Health Care Roundup: Market Talk [Yahoo! Finance]
Low
Report
Health Care Roundup: Market Talk [Yahoo! Finance]
9/10
09:20 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $48.00 price target on the stock, down previously from $63.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $48.00 price target on the stock, down previously from $63.00.
9/10
08:49 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Guggenheim. They now have a $48.00 price target on the stock, down previously from $55.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Guggenheim. They now have a $48.00 price target on the stock, down previously from $55.00.
9/10
08:00 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $48.00 price target on the stock, down previously from $70.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at Chardan Capital. They now have a $48.00 price target on the stock, down previously from $70.00.
9/10
08:00 am
trml
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock, down previously from $50.00.
Low
Report
Tourmaline Bio (NASDAQ:TRML) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock, down previously from $50.00.
9/9
06:03 pm
trml
Novartis to Acquire Tourmaline Bio in $1.4 Billion Deal [Yahoo! Finance]
Low
Report
Novartis to Acquire Tourmaline Bio in $1.4 Billion Deal [Yahoo! Finance]
9/9
05:03 pm
trml
Tourmaline Bio (NASDAQ:TRML) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
Low
Report
Tourmaline Bio (NASDAQ:TRML) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.
9/9
03:59 pm
trml
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at Lifesci Capital. They now have a $48.00 price target on the stock.
Neutral
Report
Tourmaline Bio (NASDAQ:TRML) had its "market perform" rating reaffirmed by analysts at Lifesci Capital. They now have a $48.00 price target on the stock.
9/9
03:59 pm
trml
Tourmaline Bio (NASDAQ:TRML) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $47.50 price target on the stock, down previously from $64.00.
Neutral
Report
Tourmaline Bio (NASDAQ:TRML) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $47.50 price target on the stock, down previously from $64.00.
9/9
12:06 pm
trml
This Small Biotech Stock Is Surging Today. Here's Why. [Yahoo! Finance]
Low
Report
This Small Biotech Stock Is Surging Today. Here's Why. [Yahoo! Finance]
9/9
11:51 am
trml
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW), Workhorse Group Inc. (Nasdaq - WKHS)
Low
Report
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW), Workhorse Group Inc. (Nasdaq - WKHS)
9/9
11:00 am
trml
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AL, VRNT, TRML on Behalf of Shareholders
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AL, VRNT, TRML on Behalf of Shareholders
9/9
10:53 am
trml
Novartis & Tourmaline, Anglo American & Teck, CoreWeave AI fund [Yahoo! Finance]
Low
Report
Novartis & Tourmaline, Anglo American & Teck, CoreWeave AI fund [Yahoo! Finance]
9/9
10:41 am
trml
Novartis & Tourmaline, Anglo American & Teck, CoreWeave AI fund [Yahoo! Finance Canada]
Low
Report
Novartis & Tourmaline, Anglo American & Teck, CoreWeave AI fund [Yahoo! Finance Canada]
9/9
09:45 am
trml
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense' [Yahoo! Finance]
Low
Report
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense' [Yahoo! Finance]
9/9
09:32 am
trml
Tourmaline, Anglo American, Monte Paschi: Market Movers [Yahoo! Finance]
Low
Report
Tourmaline, Anglo American, Monte Paschi: Market Movers [Yahoo! Finance]